Alector (ALEC) Cash from Operations (2018 - 2026)
Alector (ALEC) posted quarterly Cash from Operations of 49813000.0 for Q1 2026, up 18.05% year-over-year from 42197309.92 in Q1 2025, and down 19.48% quarter-over-quarter from 41691000.0 in Q4 2025.
Alector (ALEC) Cash from Operations (2018 - 2026) Analysis & Trends
Alector (ALEC) has reported Cash from Operations for 9 consecutive years, with 49813000.0 the latest figure, recorded in Q1 2026.
- In Q1 2026, Cash from Operations rose 18.05% year-over-year to 49813000.0; the TTM figure through Mar 2026 stood at 173061000.0 (up 24.54% YoY), while the FY2025 annual figure was 184031000.0, up 19.95% from the prior year.
- Cash from Operations slipped to 49813000.0 in Q1 2026 per ALEC's latest filing, from 41691000.0 in the prior quarter.
- Across five years, Cash from Operations topped out at 135091000.0 in Q1 2022 and bottomed at 62797000.0 in Q2 2024.
- Historically, Cash from Operations has averaged 39308235.29 across 5 years, with a median of 49046000.0 in 2025.
- Annual changes were most pronounced in 2022 — Cash from Operations soared 356.37% — and 2023, when it plunged 135.94%.
- Alector's Cash from Operations stood at 48925000.0 in 2022, then advanced by 5.84% to 46070000.0 in 2023, then dropped by 19.44% to 55028000.0 in 2024, then grew by 24.24% to 41691000.0 in 2025, then declined by 19.48% to 49813000.0 in 2026.
- Business Quant data shows ALEC's Cash from Operations at 49813000.0 in Q1 2026, 41691000.0 in Q4 2025, and 32511000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Operations (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 1.13 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 813.00 Mn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | -387.32 Mn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 462.82 Mn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | -1.76 Mn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 728.46 Mn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 326.72 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | -88.83 Mn |
| 10 | Alector | 218.85 Mn | 46.05 Mn | - | -34.22 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -34.22 Mn |
| Jun 30, 2026 | -34.22 Mn |
| Mar 31, 2026 | -49.81 Mn |
| Mar 31, 2026 | -49.81 Mn |
| Dec 31, 2025 | -41.69 Mn |
| Dec 31, 2025 | -41.69 Mn |
| Sep 30, 2025 | -32.51 Mn |
| Sep 30, 2025 | -32.51 Mn |
| Jun 30, 2025 | -49.05 Mn |
| Jun 30, 2025 | -49.05 Mn |
| Mar 31, 2025 | -60.78 Mn |
| Mar 31, 2025 | -60.78 Mn |
| Dec 31, 2024 | -55.03 Mn |
| Dec 31, 2024 | -55.03 Mn |
| Sep 30, 2024 | -50.73 Mn |
| Sep 30, 2024 | -50.73 Mn |
| Jun 30, 2024 | -62.80 Mn |
| Jun 30, 2024 | -62.80 Mn |
| Mar 31, 2024 | -61.35 Mn |
| Mar 31, 2024 | -61.35 Mn |